Transforming growth factor beta 3: Partner Ciba-Geigy Ltd. began a double-blind, placebo controlled Phase IB/II trial in Europe, and has filed an IND in the U.S

Oncogene Science Inc. (ONCS), Uniondale, N.Y. Product: Transforming growth factor beta 3, regulator of cell proliferation, migration, and adhesion Indication: Chronic skin wounds including diabetic fo...